Last reviewed · How we verify
Insulin (Pork) (INSULIN PORK)
Insulin Pork is a marketed insulin therapy that binds to insulin receptors to facilitate glucose uptake and lower blood sugar levels, competing in a well-established market with other insulin products. Its key strength lies in its long-standing use and familiarity among patients and healthcare providers, supported by a key composition patent expiring in 2028. The primary risk is the intense competition from same-class drugs such as insulin human, insulin beef, insulin lispro, insulin aspart, and insulin glulisine, which have been approved and widely used since the 1980s and 1990s.
At a glance
| Generic name | INSULIN PORK |
|---|---|
| Modality | Recombinant protein |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
| First approval | 1966 |
Approved indications
Common side effects
- Hypoglycemia
- Loss of diabetic control
- Lethargy
- Diarrhea
- Vomiting
- Decreased appetite/anorexia
- Disorientation and collapse
- Injection site reactions (edema, swelling, crusting, bruising)
- Weight loss
- Pancreatitis
- Urinary tract infections/disorder
- Hematuria
Serious adverse events
- Seizures (hypoglycemia-induced)
- Death during seizure
- Hepatopathy
Key clinical trials
- Effects of Common Meals on Appetite and Satiety (NA)
- Reducing Insulin, Growth Hormones, and Tumors (NA)
- Effects of Lean Pork, High Protein Breakfast on Satiety and Metabolic Health in Pre-diabetes (NA)
- Egg Diet to Improve Metabolic Health and Function (NA)
- Adding Metformin to Insulin in Controlling Pregestational and Gestational Diabetes Mellitus (NA)
- Basal-bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes (PININ Study) (PHASE4)
- Assessment of Cod Protein as an Insulin-sensitizing Agent in Women With Polycystic Ovary Syndrome. (NA)
- To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Insulin (Pork) CI brief — competitive landscape report
- Insulin (Pork) updates RSS · CI watch RSS